InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.950
+0.020 (0.68%)
Apr 23, 2025, 4:00 PM EDT - Market closed
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $3.56 million as of April 23, 2025. Its market cap has increased by 78.05% in one year.
Market Cap
3.56M
Enterprise Value
1.05M
1-Year Change
78.05%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $3.56M, a decrease of -86.30%. That is a compound annual growth rate of -36.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 3.60M | 5.88% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.25B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |